CIK 0001679628 · <br>Emerging growth company
JUPITER NEUROSCIENCES, INC.
Sign in to watch- Ticker
- JUNS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474828381
- Phone
- (561) 406-6154
- Business address
- 1001 NORTH US HWY 1, SUITE 504, JUPITER, FL, 33477
- Former names
- Jupiter Orphan Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-31 | Cutler Andrew Jon Director | Grant or award · Stock Option (right to buy) | +472,222 | 472,222 | ||
| 2026-06-29 | Philipson Tomas Jan Director | Grant or award · Stock Option (right to buy) | +536,428 | 536,428 | ||
| 2026-06-02 | Brady Allison W Director | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2026-06-02 | Elmasri Saleem Chief Financial Officer | Grant or award · Stock Option | +525,565 | 525,565 | ||
| 2026-06-02 | ROSEN CHRISTER CEO and Chairman | Grant or award · Stock Option | +747,783 | 747,783 | ||
| 2026-06-02 | Hemmerly Nicholas H. Director | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2026-06-02 | Kampf Julie B. Director | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2026-06-02 | Silva Alison D. President and COO | Grant or award · Stock Option | +1,027,304 | 1,027,304 | ||
| 2026-06-02 | Hayward Marshall A. Chief Scientific Officer | Grant or award · Stock Option | +259,231 | 259,231 | ||
| 2026-06-02 | Weis Holger Director | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2026-06-02 | Rosen Alexander Gustaf Erik Chief Administrative Officer | Grant or award · Stock Option | +341,843 | 341,843 | ||
| 2026-03-02 | Hayward Marshall A. Chief Scientific Officer | Option exercise | +225,000 | 2,995,077 | ||
| 2026-03-02 | Hayward Marshall A. Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −225,000 | 0 | ||
| 2025-07-02 | Elmasri Saleem CFO and Secretary | Grant or award · Stock Option (right to buy) | +102,128 | 102,128 | ||
| 2025-07-02 | Silva Alison D. Pres + Chief Business Officer | Grant or award · Stock Option (right to buy) | +255,320 | 255,320 | ||
| 2025-07-01 | Silva Alison D. Pres + Chief Business Officer | Purchase | +250 | $1.03 | $257 | 112,277 |
| 2025-07-01 | Silva Alison D. Pres + Chief Business Officer | Purchase | +250 | $1.03 | $257 | 112,527 |
| 2025-07-01 | Silva Alison D. Pres + Chief Business Officer | Purchase | +250 | $1.03 | $259 | 112,777 |
| 2025-07-01 | ROSEN CHRISTER CEO and Chairman | Purchase | +500 | $1.01 | $505 | 11,075,792 |
| 2025-07-01 | ROSEN CHRISTER CEO and Chairman | Purchase | +3,100 | $1.02 | $3K | 11,078,892 |
Page 1 of 3 · 58 trades